Evidence-based clinical use of insulin premixtures

Brazil is expected to have 19.6 million patients with diabetes by the year 2030. A key concept in the treatment of type 2 diabetes mellitus (T2DM) is establishing individualized glycemic goals based on each patient’s clinical characteristics, which impact the choice of antihyperglycemic therapy. Tar...

Descripción completa

Detalles Bibliográficos
Autores principales: Tambascia, Marcos Antônio, Nery, Márcia, Gross, Jorge Luiz, Ermetice, Mariana Narbot, de Oliveira, Carolina Piras
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016222/
https://www.ncbi.nlm.nih.gov/pubmed/24011173
http://dx.doi.org/10.1186/1758-5996-5-50

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016222/
https://www.ncbi.nlm.nih.gov/pubmed/24011173
http://dx.doi.org/10.1186/1758-5996-5-50

Ejemplares similares